Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
10/2003
10/30/2003US20030203836 Methods for reduced renal uptake of protein conjugates
10/30/2003US20030203472 Episome for transfer and expression of heterologous nucleotide sequences in gram positive bacteria; genetic vaccines
10/30/2003US20030203426 Comprises proteins for diagnosis, treatment and prevention of arthritis, muscular, cancer, nervous system, sex and urogenital disorders
10/30/2003US20030203406 Human methionine aminopeptidase type 3
10/30/2003US20030203402 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/30/2003US20030203401 Comprises nucleotide sequences coding membrane protein for diagnosing, preventing and treating cell proliferative, inflammatory or tumor disorders
10/30/2003US20030203361 13 human colon and colon cancer associated proteins
10/30/2003US20030203053 Method and composition for improving sexual fitness
10/30/2003US20030202991 Delivery of biologically active polypeptides
10/30/2003US20030202989 Use of toxin peptides and/or affinity handles for delivering compounds into cells
10/30/2003US20030202988 Attenuated mutant; induce immunology response
10/30/2003US20030202987 Hepatitis virus; oligomer protein
10/30/2003US20030202985 Methods and compositions for immunotherapy of cancer
10/30/2003US20030202983 Protein for medical diagnosis; preventing infections; genetic engineering
10/30/2003US20030202982 Genetic engineering
10/30/2003US20030202980 Methods and reagents for decreasing clinical reaction to allergy
10/30/2003US20030202979 Mixture of lecithin and polymer
10/30/2003US20030202978 Spray freeze-dried compositions
10/30/2003US20030202976 Methods and reagents for diagnosis and treatment of diabetes
10/30/2003US20030202975 Using monoclonal antibodies; shrinkage of solid tumors
10/30/2003US20030202972 Stability; freeze drying; regeneration
10/30/2003US20030202971 Genetic engineering; binding polypeptide to antibody ; screening, modulation, calibration
10/30/2003US20030202963 Method of treating cancer
10/30/2003US20030202962 Antigen encoded nucleic acids; controlling cell differentiation, cell proliferation; transcription factor controller
10/30/2003EP1496982A2 Solid forms of salts with tyrosine kinase activity
10/30/2003CA2483476A1 Fusion polypeptides and methods for inhibiting microbial adhesion
10/30/2003CA2483474A1 Lewis y epitope modified polypeptide, or mucin fusion polypetide, tumor vaccines
10/30/2003CA2483473A1 Mucin fusion polypeptide vaccines, compositions and methods of use thereof
10/30/2003CA2483327A1 Oligonucleotides from coding sequences for the surface component of ptlvenvelope proteins and uses thereof
10/30/2003CA2482993A1 Inhibition of ii expression in mammalian cells
10/30/2003CA2482924A1 Adjuvant enhanced immunotherapy
10/30/2003CA2482907A1 Tissue specific genes and gene clusters
10/30/2003CA2482764A1 Cell wall mannoproteins and active epitopes from candida albicans and antibodies recognizing them
10/30/2003CA2482477A1 Synthetic glyco-lipo-peptides as vaccines
10/30/2003CA2482183A1 Method of treating biological materials with translating electrical fields and electrode polarity reversal
10/30/2003CA2481952A1 Immunological methods and compositions for the treatment of alzheimer's disease
10/30/2003CA2481108A1 Tuberculosis vaccines including recombinant bcg strains expressing alanine dehydrogenase, serine dehydratase and/or glutamine synthetase
10/30/2003CA2481085A1 Compositions and methods for the diagnosis and treatment of tumor
10/30/2003CA2480437A1 Methods of identifying compounds that modulate a dna repair pathway and/or retroviral infectivity, the compounds, and uses thereof
10/30/2003CA2480404A1 Fc receptor homolog, reagents, and uses thereof
10/30/2003CA2480325A1 Solid forms of salts with tyrosine kinase activity
10/30/2003CA2478009A1 Modified vaccinia virus ankara for the vaccination of neonates
10/30/2003CA2466229A1 Use of il-19, il-22 and il-24 to treat hematopoietic disorders
10/29/2003EP1357131A2 Treatment of lupus nephritis with anti-CD4OL compounds
10/29/2003EP1357128A1 The preparation and usage of plasmodium fusion antigen
10/29/2003EP1357127A1 Hepatitis c virus epitopes specific for cd4+ t-cell lymphocytes
10/29/2003EP1356829A2 Preparation of virally inactivated intravenously injectable immune serum globulin
10/29/2003EP1356826A1 Microparticles comprising carbohydrate beads covalently linked with allergen
10/29/2003EP1356824A2 88KDA tumorigenic growth factor and antagonists
10/29/2003EP1356823A2 Use of skin penetration enhancers and barrier disruption agents to enhance transcutaneous immune response induced by ADP-ribosylating exotoxin
10/29/2003EP1356822A2 Pharmaceutical compositions enhancing the immunogenicity of poorly immunogenic antigens
10/29/2003EP1356821A2 Use of skin penetration enhancers and barrier disruption agents to enhance transcutaneous immune response INDUCED BY ADP-RIBOSYLATING EXOTOXIN
10/29/2003EP1356820A1 DNA vaccine combined with an inducer of tumor cell apoptosis
10/29/2003EP1356818A2 Drug, in particular for modulating the immunological response for the control of viruses, tumours, bacteria and parasites
10/29/2003EP1356285A2 Differentially expressed epitopes and uses thereof
10/29/2003EP1356278A2 Methods and compositions for the identification and treatment of neurodegenerative disorders
10/29/2003EP1356095A2 Method for identifying metastatic tumor cells
10/29/2003EP1356092A2 Compositions and methods for the therapy and diagnosis of ovarian cancer
10/29/2003EP1356091A2 Method of detecting inflammatory lung disorders
10/29/2003EP1356079A2 Srebp pathway modulation through targeting hisrs
10/29/2003EP1356052A2 Prokaryotically produced antibodies and uses thereof
10/29/2003EP1356048A2 Cytotoxic t-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer
10/29/2003EP1356047A2 Human proteins, polynucleotides encoding them and methods of using the same
10/29/2003EP1356046A2 Cytokine receptor zcytor19
10/29/2003EP1356043A2 Novel proteins and nucleic acids encoding same and antibodies directed against these proteins
10/29/2003EP1356042A2 Carbohydrate-associated proteins
10/29/2003EP1356038A2 Compositions and methods relating to lung specific genes and proteins
10/29/2003EP1356028A2 Protein modification and maintenance molecules
10/29/2003EP1355949A1 Conformationally abnormal forms of tau proteins and specific antibodies thereto
10/29/2003EP1355947A2 Monoclonal antibodies specific for the e2 glycoprotein of hepatitis c virus and their use in the diagnosis, treatment, and prevention of hepatitis c
10/29/2003EP1355944A2 Rtvp based compositions and methods for the treatment of prostate cancer
10/29/2003EP1355937A2 Mammalian alpha-helical protein-53
10/29/2003EP1355936A2 Polymer conjugates of neublastin and methods of using same
10/29/2003EP1355935A2 Secreted proteins
10/29/2003EP1355934A2 Compositions and methods relating to lung specific genes and proteins
10/29/2003EP1355930A2 A method for identification, isolation and production of antigens to a specific pathogen
10/29/2003EP1355929A2 Basb209 polypeptides and polynucleotides from haemophilus influenzae
10/29/2003EP1355928A1 Universal carrier for targeting molecules to gb3 receptor expressing cells
10/29/2003EP1355926A2 Therapeutic compounds for ovarian cancer
10/29/2003EP1355925A2 Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses
10/29/2003EP1355923A2 Immunomodulatory peptides derived from heat shock proteins and uses thereof
10/29/2003EP1355922A2 Stress proteins and peptides and methods of use thereof
10/29/2003EP1355919A2 Molecules with extended half-lives, compositions and uses thereof
10/29/2003EP1355918A2 Recombinant protective protein from $i(streptococcus pneumoniae)
10/29/2003EP1355917A2 Compositions and methods relating to breast specific genes and proteins
10/29/2003EP1355673A2 Multivalent meningococcal polysaccharide-protein conjugate vaccine
10/29/2003EP1355668A1 Use of il-18 inhibitors for the treatment and/or prevention of heart disease
10/29/2003EP1355667A2 Novel fibronectin epitopes and proteinaceous molecules capable of binding said epitopes
10/29/2003EP1355666A2 Use of rgm and its modulators
10/29/2003EP1355665A2 Treatment of juvenile rheumatioid arthritis by oral administration of pooled human immunoglobulin and an antacid
10/29/2003EP1355664A2 Methods employing and compositions containing plaque associated molecules for prevention and treatment of atherosclerosis
10/29/2003EP1355663A1 Method for treating an hiv-infected individual by combining immunization with structured interruption of anti-retroviral treatment
10/29/2003EP1355661A2 Tumor vaccine
10/29/2003EP1355658A1 Pyk2 phosphorylation by her3 induces tumor invasion
10/29/2003EP1355656A2 Red blood cell as vehicle for agent-membrane translocation sequence conjugate
10/29/2003EP1355653A2 Stimulation of thymus for vaccination development
10/29/2003EP1355634A2 Sn-38 lipid complexes and methods of use
10/29/2003EP1355628A2 Stabilised polymeric aerosols for pulmonary gene delivery
10/29/2003EP1355563A2 METHODS FOR THE PREVENTION AND TREATMENT OF CANCER USING ANTI-C3B(i) ANTIBODIES
10/29/2003EP1235787B1 $g(b)2-ADRENERGIC RECEPTOR AGONISTS
1 ... 1201 1202 1203 1204 1205 1206 1207 1208 1209 1210 1211 1212 1213 1214 1215 1216 1217 1218 1219 1220 1221 ... 1823